Suppr超能文献

囊性纤维化患儿的气道重塑

Airway remodelling in children with cystic fibrosis.

作者信息

Hilliard Tom N, Regamey Nicolas, Shute Janis K, Nicholson Andrew G, Alton Eric W F W, Bush Andrew, Davies Jane C

机构信息

Department of Gene Therapy, National Heart and Lung Institute, Imperial College, London, UK.

出版信息

Thorax. 2007 Dec;62(12):1074-80. doi: 10.1136/thx.2006.074641. Epub 2007 May 25.

Abstract

BACKGROUND

The relationship between airway structural changes and inflammation is unclear in early cystic fibrosis (CF) lung disease. A study was undertaken to determine changes in airway remodelling in children with CF compared with appropriate disease and healthy controls.

METHODS

Bronchoalveolar lavage and endobronchial biopsy were performed in a cross-sectional study of 43 children with CF (aged 0.3-16.8 years), 7 children with primary ciliary dyskinesia (PCD), 26 with chronic respiratory symptoms (CRS) investigated for recurrent infection and/or cough and 7 control children with no lower airway symptoms. Inflammatory cells, cytokines, proteases and matrix constituents were measured in bronchoalveolar lavage fluid (BALF). Reticular basement membrane (RBM) thickness was measured on biopsy specimens using light microscopy.

RESULTS

Increased concentrations of elastin, glycosaminoglycans and collagen were found in BALF from children with CF compared with the CRS group and controls, each correlating positively with age, neutrophil count and proteases (elastase activity and matrix metalloproteinase-9 (MMP-9) concentration). There were significant negative correlations between certain of these and pulmonary function (forced expiratory volume in 1 s) in the CF group (elastin: r = -0.45, p<0.05; MMP-9:TIMP-1 ratio: r = -0.47, p<0.05). Median RBM thickness was greater in the CF group than in the controls (5.9 microm vs 4.0 microm, p<0.01) and correlated positively with levels of transforming growth factor-beta(1) (TGF-beta(1); r = 0.53, p = 0.01), although not with other inflammatory markers or pulmonary function.

CONCLUSIONS

This study provides evidence for two forms of airway remodelling in children with CF: (1) matrix breakdown, related to inflammation, proteolysis and impaired pulmonary function, and (2) RBM thickening, related to TGF-beta(1) concentration but independent of other markers of inflammation.

摘要

背景

在早期囊性纤维化(CF)肺部疾病中,气道结构变化与炎症之间的关系尚不清楚。开展了一项研究,以确定与适当疾病和健康对照相比,CF患儿气道重塑的变化。

方法

对43例CF患儿(年龄0.3 - 16.8岁)、7例原发性纤毛运动障碍(PCD)患儿、26例因反复感染和/或咳嗽而接受慢性呼吸道症状(CRS)调查的患儿以及7例无下呼吸道症状的对照儿童进行了横断面研究,实施支气管肺泡灌洗和支气管活检。在支气管肺泡灌洗液(BALF)中测量炎性细胞、细胞因子、蛋白酶和基质成分。使用光学显微镜在活检标本上测量网状基底膜(RBM)厚度。

结果

与CRS组和对照组相比,CF患儿BALF中弹性蛋白、糖胺聚糖和胶原蛋白浓度增加,每种物质均与年龄、中性粒细胞计数和蛋白酶(弹性蛋白酶活性和基质金属蛋白酶 - 9(MMP - 9)浓度)呈正相关。在CF组中,其中某些物质与肺功能(1秒用力呼气量)之间存在显著负相关(弹性蛋白:r = -0.45,p<0.05;MMP - 9:TIMP - 1比值:r = -0.47,p<0.05)。CF组的RBM厚度中位数大于对照组(5.9微米对4.0微米,p<0.01),并且与转化生长因子 - β(1)(TGF - β(1))水平呈正相关(r = 0.53,p = 0.01),尽管与其他炎症标志物或肺功能无关。

结论

本研究为CF患儿气道重塑的两种形式提供了证据:(1)与炎症、蛋白水解和肺功能受损相关的基质分解,以及(2)与TGF - β(1)浓度相关但独立于其他炎症标志物的RBM增厚。

相似文献

1
Airway remodelling in children with cystic fibrosis.
Thorax. 2007 Dec;62(12):1074-80. doi: 10.1136/thx.2006.074641. Epub 2007 May 25.
2
Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
Thorax. 2012 Feb;67(2):164-70. doi: 10.1136/thoraxjnl-2011-200585. Epub 2011 Oct 18.
3
Ventilation Inhomogeneity and Bronchial Basement Membrane Changes in Chronic Neutrophilic Airway Inflammation.
Chest. 2020 Apr;157(4):779-789. doi: 10.1016/j.chest.2019.10.023. Epub 2019 Nov 9.
6
Lung function in infants with cystic fibrosis diagnosed by newborn screening.
Am J Respir Crit Care Med. 2008 Dec 15;178(12):1238-44. doi: 10.1164/rccm.200804-551OC. Epub 2008 Sep 11.
9
Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index.
Am J Respir Crit Care Med. 2012 Apr 15;185(8):862-73. doi: 10.1164/rccm.201109-1631OC. Epub 2012 Feb 9.

引用本文的文献

2
Tailored Levofloxacin Incorporated Extracellular Matrix Nanoparticles for Pulmonary Infections.
Int J Mol Sci. 2025 Aug 1;26(15):7453. doi: 10.3390/ijms26157453.
3
Wound repair and immune function in the infected CF lung: before and after highly effective modulator therapy.
Front Cell Infect Microbiol. 2025 Apr 28;15:1566495. doi: 10.3389/fcimb.2025.1566495. eCollection 2025.
4
Beyond the present: current and future perspectives on the role of infections in pediatric PCD.
Front Pediatr. 2025 Mar 18;13:1564156. doi: 10.3389/fped.2025.1564156. eCollection 2025.
5
Immunomodulatory activity of omadacycline and in a murine model of acute lung injury.
mSphere. 2024 Nov 21;9(11):e0067124. doi: 10.1128/msphere.00671-24. Epub 2024 Oct 30.
6
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):417-448. doi: 10.1007/s00210-024-03392-1. Epub 2024 Aug 28.
7
in cystic fibrosis children and adolescents: overall survival and immune alterations.
Front Cell Infect Microbiol. 2024 Jul 1;14:1374318. doi: 10.3389/fcimb.2024.1374318. eCollection 2024.
8
Epithelial-Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
Int J Mol Sci. 2023 Aug 3;24(15):12412. doi: 10.3390/ijms241512412.

本文引用的文献

1
Genetic modifiers of lung disease in cystic fibrosis.
N Engl J Med. 2005 Oct 6;353(14):1443-53. doi: 10.1056/NEJMoa051469.
3
Structural changes to airway smooth muscle in cystic fibrosis.
Thorax. 2005 Mar;60(3):226-8. doi: 10.1136/thx.2004.028340.
4
Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction.
Am J Respir Crit Care Med. 2005 Apr 1;171(7):722-7. doi: 10.1164/rccm.200410-1404OC. Epub 2005 Jan 18.
6
Extracellular matrix regulates human airway smooth muscle cell migration.
Eur Respir J. 2004 Oct;24(4):545-51. doi: 10.1183/09031936.04.00113103.
7
The role of transforming growth factor beta in lung development and disease.
Chest. 2004 Feb;125(2):754-65. doi: 10.1378/chest.125.2.754.
8
The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis.
Am J Respir Crit Care Med. 2004 Apr 15;169(8):928-33. doi: 10.1164/rccm.200309-1344OC. Epub 2004 Jan 30.
9
Pathophysiology and management of pulmonary infections in cystic fibrosis.
Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. doi: 10.1164/rccm.200304-505SO.
10
Airway inflammation in childhood asthma.
Am J Respir Crit Care Med. 2003 Oct 1;168(7):798-803. doi: 10.1164/rccm.200305-650OC. Epub 2003 Jul 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验